PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:05 AM ET

Sponsor Check › Person

ML
No photo found yet (own website and image search run after this page is viewed)

Mark Levin

Named as an officer, director or promoter on SEC Form D filings · MA · Oct 8, 2009 → Jan 25, 2021

9deals (issuers)
$883.5Mreported sold
178investors
23Form D filings
2009–2021years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Mark Levin is listed as an executive officer and director on 23 SEC Form D filings by 9 issuers between Oct 2009 and Jan 2021. Largest by amount reported sold: Third Rock Ventures III, L.P. (Boston, MA — pooled investment fund — 2013; $500M reported sold to 58 investors), CONSTELLATION PHARMACEUTICALS INC (Cambridge, MA — biotechnology — 2010–2011; $99M reported sold to 30 investors), Fulcrum Therapeutics, Inc. (Cambridge, MA — biotechnology — 2016–2020; $80M reported sold to 20 investors), Voyager Therapeutics, Inc. (Lexington, MA — biotechnology — 2015; $60M reported sold to 10 investors), Foundation Medicine, Inc. (Cambridge, MA — biotechnology — 2010–2013; $56M reported sold to 22 investors) and 4 more (all listed below).

What this means A repeat sponsor — 9 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $883.5M sold in total.

Listed alongside James Geraghty (6 shared filings), Robert Gould (5 shared filings), Robert Tepper (5 shared filings), Alan Ezekowitz (4 shared filings), David S. Celermajer (4 shared filings) and 58 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.

1 of the issuers belongs to the sponsor group Third Rock (7 issuers, $2.62B reported sold, 2010–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Third Rock has 7 companies on file and $2.62B reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 12 bankruptcy cases matching the name listed in Key records below.

What this means 13 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 23 public filings for Mark Levin and found 10 differences: Mark Levin's role changed at NinePoint Medical, Inc.: executive officer, director → director; Offering amount changed between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Mark Levin has not run yet — it is joining a line of 6,145 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 dismissed

E.F.HUTTON & CO.,INC. v. MARK J. LEVIN dismissed
District Court, N.D. California · No. · Filed Nov 6, 1987 · Closed Feb 16, 1989 · Nature of suit: 190 Other contract actions
Role of MARK J. LEVIN: Defendant · Outcome: Terminated 1989-02-16 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in CA (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mark Levin..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

12 cases: 12 closed (disposition not in docket feed)

Mark C. Levin closed
United States Bankruptcy Court, M.D. Florida · No. 6:18-bk-02271 · Filed Apr 20, 2018 · Closed May 11, 2020
Role of Mark C. Levin: Debtor · Outcome: Case closed 2020-05-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in FL (not a filing state)
Mark S. Levin closed
United States Bankruptcy Court, E.D. Pennsylvania · No. 14-11919 · Filed Mar 14, 2014 · Closed Aug 5, 2014
Role of Mark S. Levin: Debtor · Outcome: Case closed 2014-08-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in PA (not a filing state)
Mark B Levin and Janice A Levin closed
United States Bankruptcy Court, N.D. Illinois · No. 14-04919 · Filed Feb 17, 2014 · Closed May 23, 2014
Role of Mark B Levin and Janice A Levin: Debtor · Outcome: Case closed 2014-05-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in IL (not a filing state)
Mark B. Levin closed
United States Bankruptcy Court, E.D. Texas · No. 13-60869 · Filed Nov 5, 2013 · Closed Apr 23, 2019
Role of Mark B. Levin: Debtor · Outcome: Case closed 2019-04-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in TX (not a filing state)
Mark B Levin closed
United States Bankruptcy Court, D. Kansas · No. 08-22898 · Filed Nov 5, 2008 · Closed May 10, 2012
Role of Mark B Levin: Debtor · Outcome: Case closed 2012-05-10 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in KS (not a filing state)
Mark C. Levin and Anita M. Levin closed
United States Bankruptcy Court, D. Maryland · No. 03-57164 · Filed Apr 28, 2003 · Closed May 6, 2005
Role of Mark C. Levin and Anita M. Levin: Debtor · Outcome: Case closed 2005-05-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in MD (not a filing state)
Mark E Levin and Susan Levin closed
United States Bankruptcy Court, E.D. North Carolina · No. 02-09064 · Filed Oct 29, 2002 · Closed Apr 14, 2003
Role of Mark E Levin and Susan Levin: Debtor · Outcome: Case closed 2003-04-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in NC (not a filing state)
Mark Levin closed
United States Bankruptcy Court, E.D. Pennsylvania · No. 02-11166 · Filed Jan 25, 2002 · Closed Jun 20, 2002
Role of Mark Levin: Debtor · Outcome: Case closed 2002-06-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in PA (not a filing state)
Mark L. Levin and Susan C. Verzier-Levin closed
United States Bankruptcy Court, D. Maryland · No. 00-60866 · Filed Aug 30, 2000 · Closed Dec 5, 2000
Role of Mark L. Levin and Susan C. Verzier-Levin: Debtor · Outcome: Case closed 2000-12-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in MD (not a filing state)
Mark Levin closed
United States Bankruptcy Court, E.D. Pennsylvania · No. 00-10828 · Filed Jan 21, 2000 · Closed Aug 2, 2000
Role of Mark Levin: Debtor · Outcome: Case closed 2000-08-02 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in PA (not a filing state)
Mark S. Levin closed
United States Bankruptcy Court, C.D. California · No. 9:94-bk-13247 · Filed Aug 1, 1994 · Closed Nov 30, 1995
Role of Mark S. Levin: Debtor · Outcome: Case closed 1995-11-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in CA (not a filing state)
Mark M. Levin closed
United States Bankruptcy Court, D. Massachusetts · No. 90-17172 · Filed Dec 3, 1990 · Closed May 15, 1991
Role of Mark M. Levin: Debtor · Outcome: Case closed 1991-05-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 22 federal dockets); 4 people with this name in Form D filings; court in the person's filing state (MA)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Mark Levin (compared 23 filings on Oct 24, 2026)

Note · Oct 8, 2009 – Mar 18, 2014

Mark Levin's role changed at NinePoint Medical, Inc.: executive officer, director → director

The Oct 8, 2009 filing lists Mark Levin as executive officer, director; the Mar 18, 2014 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Oct 8, 2009 ↗Form D · Mar 18, 2014 ↗Mark Levin — PartnerFacts page ↗NinePoint Medical, Inc. — PartnerFacts page ↗
Sources
Note · Sep 21, 2012 – Jan 10, 2013

Offering amount changed between filings — Foundation Medicine, Inc.

The Sep 21, 2012 filing says $42,499,987 offered; the Jan 10, 2013 Form D/A says $55,962,423.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Sep 21, 2012 ↗Form D/A (later) · Jan 10, 2013 ↗Foundation Medicine, Inc. — PartnerFacts page ↗
Sources
Note · Sep 24, 2009 – Jan 25, 2021

9 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Corvia Medical, Inc. (latest filing Jan 25, 2021) · No amendment in the last 12 months on an offering that may still be open — Fulcrum Therapeutics, Inc. (latest filing Jul 25, 2017) · No amendment in the last 12 months on an offering that may still be open — NinePoint Medical, Inc. (latest filing Nov 25, 2015) · No amendment in the last 12 months on an offering that may still be open — Voyager Therapeutics, Inc. (latest filing Apr 23, 2015) · No amendment in the last 12 months on an offering that may still be open — NinePoint Medical, Inc. (latest filing Mar 18, 2014) · and 4 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jan 25, 2021 ↗Corvia Medical, Inc. — PartnerFacts page ↗Form D/A · Jul 25, 2017 ↗Fulcrum Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Dec 5, 2023

Same name, different state: "Mark Levin" (NY) is a separate record

This page covers filings where the address state is MA. A separate record, "Mark Levin" with address state NY, is listed on 1 filing — most recently by Hirshmark Capital REIT LLC (Dec 5, 2023). The two records do not overlap in time: this page runs Oct 8, 2009 to Jan 25, 2021; the other has one filing dated Dec 5, 2023.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Mark Levin (NY) — PartnerFacts page ↗Form D · Dec 5, 2023 ↗Hirshmark Capital REIT LLC — PartnerFacts page ↗Mark Levin (MA) — this page ↗
Sources
Note · Dec 8, 2010 – Oct 3, 2016

Same name, different state: "Mark Levin" (MD) is a separate record

This page covers filings where the address state is MA. A separate record, "Mark Levin" with address state MD, is listed on 5 filings — most recently by Maki Shop Store 3 LLC (Oct 3, 2016). Both records have filings in the same period (Dec 8, 2010 to Oct 3, 2016).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Mark Levin (MD) — PartnerFacts page ↗Form D · Oct 3, 2016 ↗Maki Shop Store 3 LLC — PartnerFacts page ↗Mark Levin (MA) — this page ↗
Sources
Note · Jan 25, 2010 – Jun 4, 2012

Same name, different state: "Mark L Levin" (CA) is a separate record

This page covers filings where the address state is MA. A separate record, "Mark L Levin" with address state CA, is listed on 4 filings — most recently by Summation Sigma Fund 1, LP (Jun 4, 2012). Both records have filings in the same period (Jan 25, 2010 to Jun 4, 2012).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Mark L Levin (CA) — PartnerFacts page ↗Form D/A · Jun 4, 2012 ↗Summation Sigma Fund 1, LP — PartnerFacts page ↗Mark Levin (MA) — this page ↗
Sources
Note · Mar 18, 2014 – Nov 25, 2015

Address moved from Cambridge, MA to Bedford, MA — NinePoint Medical, Inc.

The people listed on the Mar 18, 2014 filing give Cambridge, MA; on the Nov 25, 2015 filing they give Bedford, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Mar 18, 2014 ↗Form D · Nov 25, 2015 ↗NinePoint Medical, Inc. — PartnerFacts page ↗
Sources
Note · Oct 8, 2009 – Mar 18, 2014

Address moved from Boston, MA to Cambridge, MA — NinePoint Medical, Inc.

The people listed on the Oct 8, 2009 filing give Boston, MA; on the Mar 18, 2014 filing they give Cambridge, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Oct 8, 2009 ↗Form D · Mar 18, 2014 ↗NinePoint Medical, Inc. — PartnerFacts page ↗
Sources
Note · Apr 15, 2010 – Aug 23, 2011

Address moved from Boston, MA to Cambridge, MA — Foundation Medicine, Inc.

The people listed on the Apr 15, 2010 filing give Boston, MA; on the Aug 23, 2011 filing they give Cambridge, MA. The address now on file (One Kendall Square, Suite B3501, Cambridge, MA) is a registered-agent or shared-office address used by 16 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Apr 15, 2010 ↗Form D · Aug 23, 2011 ↗Foundation Medicine, Inc. — PartnerFacts page ↗
Sources
Note · Apr 15, 2010 – Aug 23, 2011

Reported revenue range changed between filings — Foundation Medicine, Inc.

"No Revenues" (Apr 15, 2010); then "Decline to Disclose" (Aug 23, 2011).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 15, 2010 ↗Form D · Aug 23, 2011 ↗Foundation Medicine, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 19 offerings reports sales commissions totalling $4,109,999; 0 report finder's fees; 1 reports proceeds to related persons totalling $35,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jan 25, 2021 D
Corvia Medical, Inc.
File 021-387203
$0$0$0None listed on this filingEDGAR ↗
Jun 11, 2020 D
Fulcrum Therapeutics, Inc.
File 021-368703
$4,109,999$0$0SVB Leerink LLC BrokerCheck CRD 39011 ↗EDGAR ↗
Sep 5, 2018 D
Fulcrum Therapeutics, Inc.
File 021-320649
$0$0$0None listed on this filingEDGAR ↗
Jul 25, 2017 D/A
Fulcrum Therapeutics, Inc.
File 021-267612
$0$0$0None listed on this filingEDGAR ↗
May 10, 2017 D
Fulcrum Therapeutics, Inc.
File 021-286393
$0$0$0None listed on this filingEDGAR ↗
Nov 25, 2015 D
NinePoint Medical, Inc.
File 021-251996
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2015 D/A
Corvia Medical, Inc.
File 021-220190
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2015 D
Voyager Therapeutics, Inc.
File 021-238528
$0$0$0None listed on this filingEDGAR ↗
Mar 18, 2014 D
NinePoint Medical, Inc.
File 021-213827
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2013 D
Third Rock Ventures III, L.P.
File 021-193854
$0$0$0 (est.)
An affiliate of the General Partner will receive a fee for management services. The fee will be a percentage of the aggregate subscriptions of the Issuer's limited partners.
None listed on this filingEDGAR ↗
Mar 15, 2013 D
Corvia Medical, Inc.
File 021-193422
$0$0$0None listed on this filingEDGAR ↗
Jan 10, 2013 D/A
Foundation Medicine, Inc.
File 021-184482
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Aug 23, 2011 D
Foundation Medicine, Inc.
File 021-164823
$0$0$0None listed on this filingEDGAR ↗
Jun 6, 2011 D
CONSTELLATION PHARMACEUTICALS INC
File 021-160851
$0$0$0None listed on this filingEDGAR ↗
Oct 13, 2010 D/A
Eleven Biotherapeutics, Inc.
File 021-138996
$0$0$0
None other than salaries and bonuses in the ordinary course of business.
None listed on this filingEDGAR ↗
Jun 2, 2010 D
CONSTELLATION PHARMACEUTICALS INC
File 021-142827
$0$0$0None listed on this filingEDGAR ↗
Apr 15, 2010 D
Foundation Medicine, Inc.
File 021-140660
$0$0$35,000 (est.)None listed on this filingEDGAR ↗
Apr 9, 2010 D
Third Rock Ventures II, L.P.
File 021-140348
$0$0$0 (est.)
An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of the aggregate subscriptions of the Issuer's limited partners.
None listed on this filingEDGAR ↗
Oct 8, 2009 D
NinePoint Medical, Inc.
File 021-135073
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 9

Every issuer that named Mark Levin on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CM
Biotechnology

Corvia Medical, Inc.

Tewksbury, MA · Mar 15, 2013 → Jan 25, 2021 · 4 filings
  • Jan 25, 2021 · D · $6,265,647 sold of $13,115,114 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 22, 2015 · D/A · $34,000,001 sold of $34,000,001 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2014 · D · $17,050,000 sold of $34,000,001 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 15, 2013 · D · $10,736,836 sold of $10,736,836 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $34M from 25 investors (100% of the $13.1M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FT
Biotechnology

Fulcrum Therapeutics, Inc.

Cambridge, MA · Jul 25, 2016 → Jun 11, 2020 · 5 filings
  • Jun 11, 2020 · D · $68,499,987 sold of $68,499,987 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 5, 2018 · D · $80,000,000 sold of $80,000,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 25, 2017 · D/A · $29,666,666 sold of $55,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 10, 2017 · D · $5,000,000 sold of $5,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 25, 2016 · D · $17,000,000 sold of $55,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $80M from 20 investors (100% of the $68.5M target) as of the latest filing. Mark is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NM
Other Health Care

NinePoint Medical, Inc.

Bedford, MA · Oct 8, 2009 → Nov 25, 2015 · 3 filings
  • Nov 25, 2015 · D · $30,667,046 sold of $40,664,854 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 18, 2014 · D · $34,558,476 sold of $50,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 8, 2009 · D · $5,200,000 sold of $33,200,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $34.6M from 3 investors (85% of the $40.7M target) as of the latest filing. Mark is listed as director, executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VT
Biotechnology

Voyager Therapeutics, Inc.

Lexington, MA · Apr 23, 2015
  • Apr 23, 2015 · D · $60,000,003 sold of Indefinite · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60M from 10 investors as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TR
Pooled Investment Fund

Third Rock Ventures III, L.P.

Boston, MA · Mar 25, 2013
  • Mar 25, 2013 · D · $500,000,000 sold of $500,000,000 · 58 investors · min. $150,000 · role: Executive Officer (Manager of the General Partner's general partner.) EDGAR ↗

Raised $500M from 58 investors (100% of the $500M target) as of the latest filing. Mark is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

FM
Biotechnology

Foundation Medicine, Inc.

Cambridge, MA · Apr 15, 2010 → Jan 10, 2013 · 4 filings
  • Jan 10, 2013 · D/A · $55,962,423 sold of $55,962,423 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 21, 2012 · D · $42,499,987 sold of $42,499,987 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 23, 2011 · D · $10,000,000 sold of $20,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 15, 2010 · D · $7,000,000 sold of $25,000,000 · 1 investors · min. $7,000,000 · role: Director EDGAR ↗

Raised $56M from 22 investors (100% of the $56M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

CP
Biotechnology · group: Third Rock

CONSTELLATION PHARMACEUTICALS INC

Cambridge, MA · Jun 2, 2010 → Jun 6, 2011 · 2 filings
  • Jun 6, 2011 · D · $15,000,000 sold of $15,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 2, 2010 · D · $22,250,000 sold of $22,250,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $99M from 30 investors (100% of the $15M target) as of the latest filing. Mark is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

EB
Biotechnology

Eleven Biotherapeutics, Inc.

Cambridge, MA · Feb 24, 2010 → Oct 13, 2010 · 2 filings
  • Oct 13, 2010 · D/A · $8,750,000 sold of $35,000,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 24, 2010 · D · $4,500,000 sold of $35,000,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $20M from 10 investors (57% of the $35M target) as of the latest filing. Mark is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

TR
Pooled Investment Fund

Third Rock Ventures II, L.P.

Boston, MA · Apr 9, 2010
  • Apr 9, 2010 · D · $0 sold of $400,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Member of the GP LLC) EDGAR ↗

No sales reported yet as of the latest filing. Mark is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Mark Levin — MD, 4 issuers, Dec 8, 2010 → Oct 3, 2016 · no shared issuer
  • Mark L Levin — CA, 1 issuer, Jan 25, 2010 → Jun 4, 2012 · no shared issuer
  • Mark Levin — NY, 1 issuer, Dec 5, 2023 → Dec 5, 2023 · no shared issuer

People around Mark 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

TR
Management entity

Third Rock Ventures GP II, L.P.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

TG
Management entity

TRV GP II, LLC

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

TG
Management entity

TRV GP III, LLC

Director · 1 shared filing (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

James Geraghty

Director · 6 shared filings (2 issuers) · also on 3 other issuers

James Geraghty is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Tepper

Director, Executive Officer · 5 shared filings (4 issuers) · also on 11 other issuers

Robert Tepper is on 15 issuers in total — a repeat sponsor. Their page lists every one.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Gould

Executive Officer, Director · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

AE
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Ezekowitz

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Levin. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Paul LaViolette

Director · 4 shared filings (1 issuer) · also on 19 other issuers

Paul LaViolette is on 20 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David S. Celermajer

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gerry Brunk

Director · 4 shared filings (1 issuer) · also on 4 other issuers

Gerry Brunk is on 5 issuers in total — a repeat sponsor. Their page lists every one.

GF
No photo found yet (own website and image search run after this page is viewed)
Person

GEORGE FAZIO

Executive Officer, Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

James Collins

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Levin. Their page shows their other deals.

HT
No photo found yet (own website and image search run after this page is viewed)
Person

Hemant Taneja

Director · 4 shared filings (1 issuer) · also on 82 other issuers

Hemant Taneja is on 83 issuers in total — a repeat sponsor. Their page lists every one.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Alexis Borisy

Executive Officer, Director · 3 shared filings (1 issuer) · also on 15 other issuers

Alexis Borisy is on 16 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Russell Hirsch

Director · 3 shared filings (1 issuer) · also on 11 other issuers

Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel B. Curtis

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Schenkein

Director · 3 shared filings (1 issuer) · also on 4 other issuers

David Schenkein is on 5 issuers in total — a repeat sponsor. Their page lists every one.

UG
No photo found yet (own website and image search run after this page is viewed)
Person

Uri Geiger

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Levin. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Pellini

Executive Officer, Director · 2 shared filings (1 issuer) · also on 5 other issuers

Michael Pellini is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AE
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Evnin

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

NA
No photo found yet (own website and image search run after this page is viewed)
Person

Noubar Afeyan

Director · 2 shared filings (1 issuer) · also on 13 other issuers

Noubar Afeyan is on 14 issuers in total — a repeat sponsor. Their page lists every one.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

Brook Byers

Director · 2 shared filings (1 issuer) · also on 21 other issuers

Brook Byers is on 22 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

David Goeddel

Director · 2 shared filings (1 issuer) · also on 19 other issuers

David Goeddel is on 20 issuers in total — a repeat sponsor. Their page lists every one.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Mitchell S. Bloom

Executive Officer · 2 shared filings (2 issuers) · also on 10 other issuers

Mitchell S. Bloom is on 12 issuers in total — a repeat sponsor. Their page lists every one.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Starr

Executive Officer · 2 shared filings (2 issuers) · also on 7 other issuers

Kevin Starr is on 9 issuers in total — a repeat sponsor. Their page lists every one.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

TOM MANIATIS

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Berry

Director · 2 shared filings (1 issuer) · also on 13 other issuers

David Berry is on 14 issuers in total — a repeat sponsor. Their page lists every one.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Cary Pfeffer

Executive Officer, Director · 2 shared filings (1 issuer) · also on 8 other issuers

Cary Pfeffer is on 9 issuers in total — a repeat sponsor. Their page lists every one.

KD
No photo found yet (own website and image search run after this page is viewed)
Person

Kim C. Drapkin

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Garen Bohlin

Executive Officer · 2 shared filings (1 issuer) · also on 6 other issuers

Garen Bohlin is on 7 issuers in total — a repeat sponsor. Their page lists every one.

KY
No photo found yet (own website and image search run after this page is viewed)
Person

Krishna Yeshwant

Director · 2 shared filings (1 issuer) · also on 9 other issuers

Krishna Yeshwant is on 10 issuers in total — a repeat sponsor. Their page lists every one.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Paul

Director, Executive Officer · 2 shared filings (2 issuers) · also on 4 other issuers

Steven Paul is on 6 issuers in total — a repeat sponsor. Their page lists every one.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Goldsmith

Executive Officer, Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Robert W. Hesslein

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Levin. Their page shows their other deals.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Krenitsky

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Levin. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jason Ryan

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

MARK STAUTBERG

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Levin. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Curt Weinstein

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas J. Miller

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Levin. Their page shows their other deals.

The team behind the deals

TR
Sponsor group

Third Rock

7 issuers · 15 filings · $2.62B reported sold · 2010–2026

One team, 7 deal companies. Mark Levin is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mark Levin.

Same business address

35 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 9 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Mark Levin by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 9 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Mark Levin is listed on: none on file. No website or social profile named in Third Rock Ventures III, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #332,717 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Mark Levin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →